Targeted therapies in gastric cancer and future perspectives. - Test2 - elhamkhani - TriplyDB

Targeted therapies in gastric cancer and future perspectives.

Targeted therapies in gastric cancer and future perspectives.

http://www.wikidata.org/entity/Q36471685

about

Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Comparative proteomic analysis of rats subjected to water immersion and restraint stress as an insight into gastric ulcers.Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.Clinical significance of ubiquilin 1 in gastric cancer.Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.

P2860

Q33779412-5A2B1698-69F3-4497-94F0-0B695765FD97 Q37376289-D9824E32-143E-42E1-ADBB-208637128991 Q37705824-947D38BC-509E-4033-8E47-E69720049F7A Q38429318-B4C9EEE3-57AF-4487-966D-D7F417676280 Q38642012-3AE7DAF3-FB44-4E56-9473-D6A065A30B3C Q39038545-52AC8CA2-BE13-4318-91C4-5A8BDDAE6931 Q49338529-47197131-6477-44B6-A496-F368C72C83AC Q50057702-95767952-2CD4-426D-81C3-8C7596AD16F4 Q51141565-7D99CA9A-7A49-4190-9254-49984587CE92

P2860

Targeted therapies in gastric cancer and future perspectives.

http://www.wikidata.org/entity/Q36471685

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Targeted therapies in gastric cancer and future perspectives.

@ast

Targeted therapies in gastric cancer and future perspectives.

@en

type

label

Targeted therapies in gastric cancer and future perspectives.

@ast

Targeted therapies in gastric cancer and future perspectives.

@en

prefLabel

Targeted therapies in gastric cancer and future perspectives.

@ast

Targeted therapies in gastric cancer and future perspectives.

@en

P1433

Q36471685-58769458-EB74-42C7-B3FD-898BAFE8D3E7

P1476

Q36471685-26361E22-F34C-4140-BD76-77DB6B3AA654

P2093

Q36471685-1476E182-2ADB-407A-BB9B-58FC75928BEE

Q36471685-5B5B7DDE-3390-4CA5-967A-83B3A687166E

Q36471685-A83F153C-3658-4ABD-8E08-5456F3361763

P2860

Q36471685-02B5964D-0D5A-4A0F-A238-F0C5AFEEAA9B

Q36471685-059259EC-59A1-46B0-AE6B-E477DAA7B129

Q36471685-07495DF3-282B-4B7D-985B-DA4523C5FBCB

Q36471685-08193234-FBB9-4162-82B5-CB4136DA7356

Q36471685-08663AF6-8F69-4162-AB57-DCA092540D5E

Q36471685-0B0924C7-8398-4B89-A14C-9B19FE00D9A1

Q36471685-0C3AAF02-6F97-49A5-86A0-925C18EDEB88

Q36471685-1173C1C1-9A33-4C55-9A9B-73A8CE7CA474

Q36471685-14FE7E92-D5B8-4CD5-B899-C30C26FC6788

Q36471685-169A25DA-96EC-40AD-BE43-820909A07E44

P304

Q36471685-85EB4223-0DE8-47C5-BE8C-C5DC9C96A767

P31

Q36471685-644ca325-8d92-40b9-8ab8-3a1f0b82b74a

Q36471685-DF79360E-A9DD-4E95-93F5-96E2C80D7ED6

P356

Q36471685-9913CD5D-A18A-4BD7-9778-0875BEDD5249

P407

Q36471685-E0A4A5C9-FA9C-4734-A61B-BF883A52899F

P433

Q36471685-1389463D-212B-4302-8CA5-B34FADF22004

P478

Q36471685-5E563E00-86C3-484B-9356-26D4D23739EA

P50

Q36471685-069E2A18-1D37-4598-9123-A8E6107E55B9

P577

Q36471685-E9B488B8-D16C-46D9-AAB5-8308D098D91E

P5875

Q36471685-8CFC315A-DFBD-4262-B6F1-F7D7DAD8E3A0

P698

Q36471685-2B23A19E-5377-47C0-82F5-9FD06B29C2E6

P932

Q36471685-DBAABDB0-3495-45E6-BDC7-A048E116AEAF

P356

P1433

World Journal of Gastroenterology

P1476

Targeted therapies in gastric cancer and future perspectives

@en

P2093

M Ali Nahit Sendur

http://www.w3.org/2001/XMLSchema#string

Nuriye Ozdemir

http://www.w3.org/2001/XMLSchema#string

Ozan Yazici

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Chemotherapy for advanced gastric cancer

A comprehensive pathway map of epidermal growth factor receptor signaling

Tetraspanins as therapeutic targets in hematological malignancy: a concise review

Novel CD9-targeted therapies in gastric cancer

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis

Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Nivolumab plus ipilimumab in advanced melanoma.

P304

471-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I2.471

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290973545

http://www.w3.org/2001/XMLSchema#string

P698

26811601

http://www.w3.org/2001/XMLSchema#string

P932

4716053

http://www.w3.org/2001/XMLSchema#string